Immunologic monitoring in OKT3-treated kidney graft recipients.
Zlabinger
G J
GJ
Department of Pathology, University of Vienna, Austria.
Maurer
D
D
Ulrich
W
W
Meron
G
G
Pohanka
E
E
Kovarik
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D015166:Monitoring, Immunologic; D016853:Muromonab-CD3; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3; D008775:Methylprednisolone